From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning
Advanced Science · 2024-10 · 11 (40)
DOI: 10.1002/advs.202405404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 29.08.2024. Verfasst von Yaosen Min und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Interdisciplinary Information Sciences, Tsinghua University, Beijing, 100084, China. Hauptthemen laut MEDLINE: Deep Learning, Molecular Dynamics Simulation, Protein Binding. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, "Pioneer" and "Leading Goose" R&D Program of Zheilang.
Abstract (Originalsprache)
Accurate prediction of protein‐ligand binding affinities is an essential challenge in structure‐based drug design. Despite recent advances in data‐driven methods for affinity prediction, their accuracy is still limited, partially because they only take advantage of static crystal structures while the actual binding affinities are generally determined by the thermodynamic ensembles between proteins and ligands. One effective way to approximate such a thermodynamic ensemble is to use molecular dynamics (MD) simulation. Here, an MD dataset containing 3,218 different protein‐ligand complexes is curated, and Dynaformer, a graph‐based deep learning model is further developed to predict the binding affinities by learning the geometric characteristics of the protein‐ligand interactions from the MD trajectories. In silico experiments demonstrated that the model exhibits state‐of‐the‐art scoring and ranking power on the CASF‐2016 benchmark dataset, outperforming the methods hitherto reported. Moreover, in a virtual screening on heat shock protein 90 (HSP90) using Dynaformer, 20 candidates are identified and their binding affinities are further experimentally validated. Dynaformer displayed promising results in virtual drug screening, revealing 12 hit compounds (two are in the submicromolar range), including several novel scaffolds. Overall, these results demonstrated that the approach offer a promising avenue for accelerating the early drug discovery process.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Interdisciplinary Information Sciences, Tsinghua University, Beijing, 100084, China.
- School of Life Science and Technology, Xidian University, Xi'an, 710071, Shaanxi, China.
- School of Medicine, Tsinghua University, Beijing, 100084, China.
- Department of Intelligent Systems, KTH, Stockholm, 10044, Sweden.
- Microsoft Research Asia, Beijing, 100080, China.
- Department of Electrical Engineering, Tsinghua University, Beijing, 100084, China.
ORCID-Profile: Yaosen Min, Jianyang Zeng
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- "Pioneer" and "Leading Goose" R&D Program of Zheilang
Zitieren
APA
Min, Y., Wei, Y., Wang, P., Wang, X., Li, H., Wu, N., Bauer, S., Zheng, S., Shi, Y., Wang, Y., Wu, J., Zhao, D., & Zeng, J. (2024). From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning. Advanced Science, 11(40). https://doi.org/10.1002/advs.202405404
Vancouver
Min Y, Wei Y, Wang P, Wang X, Li H, Wu N, et al. From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning. Advanced Science. 2024;11(40). doi:10.1002/advs.202405404
BibTeX
@article{Min2024,
author = {Min, Yaosen and Wei, Ye and Wang, Peizhuo and Wang, Xiaoting and Li, Han and Wu, Nian and Bauer, Stefan and Zheng, Shuxin and Shi, Yu and Wang, Yingheng and Wu, Ji and Zhao, Dan and Zeng, Jianyang},
title = {From Static to Dynamic Structures: Improving Binding Affinity Prediction with Graph‐Based Deep Learning},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {40},
doi = {10.1002/advs.202405404}
}
EUVIMED